About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology
›
top-articles
Department of Hematology
55
(top 2%)
papers
806
(top 2%)
citations
18
(top 2%)
h
-index
28
(top 2%)
g
-index
57
all documents
818
doc citations
310
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi
European Journal of Immunology
2014
78
2
Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors
Bone Marrow Transplantation
1997
77
3
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein
Blood
1996
53
4
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma
Leukemia
2014
49
5
The cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolism
Seminars in Immunopathology
2015
43
6
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation
Blood
2000
37
7
Identification of Philadelphia-negative granulocyte-macrophage colony- forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients
Blood
1994
33
8
CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF
Bone Marrow Transplantation
1998
33
9
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing
Bone Marrow Transplantation
1999
32
10
Clonogenic capacity andex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation
Bone Marrow Transplantation
1997
30
11
In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor
Bone Marrow Transplantation
1991
27
12
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide
Bone Marrow Transplantation
1994
25
13
Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: Implications for cord blood banking
Stem Cells
1995
24
14
Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood
Leukemia
1997
23
15
Acute disseminated encephalomyelitis (ADEM) after autologous peripheral blood stem cell transplant for non-Hodgkin’s lymphoma
Bone Marrow Transplantation
1999
22
16
Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors
Leukemia
1990
21
17
Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow
Blood
1992
19
18
Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application
Haematologica
1995
18
19
Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor
Experimental Hematology
2000
17
20
Density Separation and Cryopreservation of Umbilical Cord Blood Cells: Evaluation of Recovery in Short- and Long-Term Cultures
Acta Haematologica
1996
14
21
Learning from other diseases: protection and pathology in chronic fungal infections
Seminars in Immunopathology
2016
14
22
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation
Experimental Hematology
1992
14
23
Autologous bone marrow transplantation in acute myelogenous leukemia
Leukemia
1992
12
24
Stem cell purging: an intriguing dilemma
Experimental Hematology
1995
12
25
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein
Blood
1996
10
26
Techniques for Detection of Minimal Residual Disease
Leukemia and Lymphoma
1995
9
27
Stem cell manipulation: why and how performing peripheral blood progenitor cell purging
Critical Reviews in Oncology/Hematology
1997
8
28
Counterflow centrifugal elutriation: present and future
Bone Marrow Transplantation
1993
8
29
Counterflow Centrifugal Elutriation: Experimental and Clinical Applications
Stem Cells and Development
1992
7
30
Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells
Leukemia
1998
7
31
Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow
Bone Marrow Transplantation
1995
7
32
Biology and Clinical Applications of Longterm Bone Marrow Cultures
International Journal of Artificial Organs
1993
4
33
Stem cells and stem cell transplantation
Haematologica
1996
4
34
Fractionation of Chronic Myelogenous Leukemia Marrow Cells by Stroma Adherence: Implications for Marrow Purging
Leukemia and Lymphoma
1993
3
35
Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells
Stem Cells
1993
3
36
In Vitro Growth of Mobilized Peripheral Blood Progenitor Cells is Significantly Enhanced by Stem Cell Factor
Stem Cells
1997
3
37
In Vitro Manipulation of Peripheral Blood Progenitor Cell Collections
International Journal of Artificial Organs
1998
3
38
Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow
Blood
1992
3
39
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells
Blood
1999
3
40
Autologous transplantation for chronic myelogenous leukemia with mafosfamide‐treated marrow
Stem Cells
1993
2
41
Pharmacological-mediated purging with mafosfamide in acute and chronic myeloid leukemias. The Italian Study Group
Progress in Clinical and Biological Research
1990
2
42
Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients
Blood
1994
2
43
Identification of Philadelphia-negative granulocyte-macrophage colony- forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients
Blood
1994
1
44
Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy
Haematologica
1995
1
45
Biology and clinical applications of long-term bone marrow cultures
International Journal of Artificial Organs
1993
1
46
Purging the Bone Marrow in Non-Hodgkin's Lymphomas. Is There Any Evidence of its Value?
Leukemia and Lymphoma
1992
0
47
Biological aspects and clinical results of autologous bone marrow transplantation for acute myeloid leukemia
International Journal of Clinical and Laboratory Research
1992
0
48
Biological and chemical selection of ph‐negative clones
Stem Cells
1993
0
49
Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow
Blood
1992
0
50
Shc Overexpression Induces Selective Hypersensitivity to GM-CSF and Prevents Apoptosis of the GM-CSF-Dependent Acute Myelogenous Leukemia Cell Line GF-D8
Hamatologie Und Bluttransfusion
1998
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.